此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

剖腹产期间典型脊柱阻滞的评估

2026年11月10日 更新者:Brandon M Togioka、Oregon Health and Science University

通过钝针针刺感官测试预测脊柱衰竭

This will be a prospective, observational, single-center study to evaluate the accuracy of sensory testing by blunt 16-gauge plastic cannula during the 15 minutes after spinal injection for predicting spinal failure. While previous studies assessed the minimal sensory level required for painless cesarean delivery at skin incision or delivery, no studies have assessed the accuracy of sensory testing at an earlier time point.

研究概览

详细说明

Primary Objective:

1. Evaluate the accuracy of sensory testing with blunt plastic 16-gauge cannula during the 15 minutes after spinal injection for predicting spinal failure. Cephalad sensory dermatomal levels will be assessed at 1 (t1), 3 (t3), 5 (t5), 7 (t7), 9 (t9), 11 (t11), 13 (t13), and 15 (t15) minutes after intrathecal 1.6 ml 0.75% bupivacaine in 8.25% dextrose combined with 15 mcg fentanyl and 150 mcg morphine (study solution). Spinal failure, which is defined as inability to achieve a T4 level to pinprick by the 15-minute timepoint or intraoperative pain (VAS > 0) requiring treatment

Secondary Objectives:

  1. Conversion to another anesthetic technique (general anesthesia or activation of the epidural catheter)
  2. Inadequate anesthesia (analgesic supplementation with ketamine, > 20 mg propofol, > 2 mg midazolam, > 10 mg parental morphine equivalents, or intraperitoneal chloroprocaine).
  3. Patient satisfaction upon arrival to the postanesthesia care unit, rated on a 1-5 Likert scale

A sample size calculation

Population: 250 pregnant females undergoing non-emergency cesarean section delivery in the Labor & Delivery Operating Rooms at Oregon Health & Science University.

Number of Sites: Single center trial

Study Duration: Institutional Review Board approval has been obtained. Study initiation, enrollment, and data collection is expected to take 24 months. Data analysis, manuscript writing, editing, submission and revision to a peer-reviewed journal is expected to take an additional 6 months.

In summary, the study should be completed in under 3 years.

Subject Participation Duration: Total time of subject participation including time for recruitment, enrollment, data collection during the preanesthesia consult, and post-consult data collection will be less than 3 hours.

Estimated Time to Complete Enrollment: Estimated time from enrollment into study of the first subject to enrollment into study of the last subject is 24 months.

研究类型

观察性的

注册 (估计的)

250

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Oregon
      • Portland、Oregon、美国、97239
        • Oregon Health and Science University

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

15年 至 55年 (孩子、成人)

接受健康志愿者

不

有资格学习的性别

女性

取样方法

非概率样本

研究人群

Pregnant females receiving spinal or combined spinal epidural anesthesia for cesarean delivery

描述

Inclusion Criteria:

  • Patients undergoing cesarean delivery under spinal or combined spinal epidural anesthesia
  • BMI between 20 and 40 kg/m2
  • Height between 5 feet 2 inches and 5 feet 10 inches.
  • English and non-English speaking patients, if interpretive services are available

Exclusion Criteria:

  • Patient refusal
  • Contraindications to neuraxial anesthesia (coagulopathy, CNS pathology, infection at site of needle puncture)
  • Allergy to any study medications
  • Use of epidural anesthesia
  • Emergency (red) cesarean delivery
  • Conditions that impact dermatomal sensory testing including spinal cord injury with sensory deficits and abdominoplasty
  • Prison inmates
  • Decisionally impaired individuals
  • Pregnancies involving multiple fetuses

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:PROSPECTIVE

队列和干预

团体/队列
干预/治疗
Study Cohort

Healthy pregnant women of BMI between 20 and 40 kg/m2, height between 5 feet 2 inches and 5 feet 10 inches, who are having cesarean delivery under spinal or combined spinal epidural anesthesia.

Patients will receive standard intrathecal medications for urgent and scheduled cesarean delivery at the study site. All study subjects will receive bupivacaine, fentanyl, and morphine.

其他名称:
  • 马卡因

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Number of participants with spinal failure
大体时间:90 minutes

A composite outcome that will be categorized as "yes" if there is either preoperative or intraoperative spinal failure. Preoperative failure will be defined as failure to achieve a T4 level to pinprick by the 15-minute timepoint. Intraoperative failure will be defined as pain (VAS > 0) that requires anesthesia provider medication administration.

Pain will be queried at time of skin incision, fetal delivery, uterine exteriorization, uterine interiorization or end of uterine closure, and end of skin closure. If VAS > 0, the anesthesia provider will ask the patient if they would like analgesic medication.

Discomfort at any other time during the cesarean delivery that is treated with neuraxial or intravenous analgesia will also count.

Pain will be rated according to the scale: 0 = no pain, 10 = worst pain imaginable

90 minutes

次要结果测量

结果测量
措施说明
大体时间
Number of participants with conversion to another anesthetic technique
大体时间:90 minutes

Conversion to general anesthesia or activation of the epidural catheter for intraoperative pain

90 minutes
Number of participants with inadequate anesthesia
大体时间:90 minutes

Analgesic supplementation with ketamine, > 20 mg propofol, > 2 mg midazolam, > 10 mg parental morphine equivalents, or intraperitoneal chloroprocaine

90 minutes
Patient satisfaction assessed by 5-point Likert scale, minimum value=1, maximum value=5, with higher values representing better patient satisfaction
大体时间:2 Hours

Patient satisfaction upon arrival to the post-anesthesia care unit, rated on a 1-5 Likert scale with higher values representing better patient satisfaction

2 Hours

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Brandon M Togioka, MD、Oregon Health and Science University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2024年6月10日

初级完成 (估计的)

2027年12月31日

研究完成 (估计的)

2028年1月31日

研究注册日期

首次提交

2024年1月4日

首先提交符合 QC 标准的

2024年1月4日

首次发布 (实际的)

2024年1月16日

研究记录更新

最后更新发布 (实际的)

2026年11月12日

上次提交的符合 QC 标准的更新

2026年11月10日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Due to patient data protection regulations within the study site there is not a plan to make individual participant data available to other researchers. Reasonable requests emailed to the PI will considered on a case-by-case basis.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

是的

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

是的

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅